Details for New Drug Application (NDA): 077457
✉ Email this page to a colleague
The generic ingredient in OCTREOTIDE ACETATE (PRESERVATIVE FREE) is octreotide acetate. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
Summary for 077457
Tradename: | OCTREOTIDE ACETATE (PRESERVATIVE FREE) |
Applicant: | Fresenius Kabi Usa |
Ingredient: | octreotide acetate |
Patents: | 0 |
Pharmacology for NDA: 077457
Mechanism of Action | Somatostatin Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 077457
Suppliers and Packaging for NDA: 077457
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OCTREOTIDE ACETATE (PRESERVATIVE FREE) | octreotide acetate | INJECTABLE;INJECTION | 077457 | ANDA | Fresenius Kabi USA, LLC | 63323-376 | 63323-376-01 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-376-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-376-00) |
OCTREOTIDE ACETATE (PRESERVATIVE FREE) | octreotide acetate | INJECTABLE;INJECTION | 077457 | ANDA | Fresenius Kabi USA, LLC | 63323-376 | 63323-376-04 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-376-04) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-376-41) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.05MG BASE/ML | ||||
Approval Date: | Feb 10, 2006 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.1MG BASE/ML | ||||
Approval Date: | Feb 10, 2006 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.5MG BASE/ML | ||||
Approval Date: | Feb 10, 2006 | TE: | AP | RLD: | No |
Complete Access Available with Subscription